Association of the C-reactive protein–triglyceride–glucose index with metabolic dysfunction-associated steatotic liver disease and long-term all-cause and cardiovascular mortality: evidence from two nationwide prospective cohort studies

Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked to cardiometabolic disorders, and cardiovascular disease is the leading cause of death among affected individuals. Identifying simple biomarkers that capture metabolic–inflammatory burden and predi...

Descripción completa

Detalles Bibliográficos

Autores principales:	Xue-Feng Jin, Zhao-Jie Su, Jian-Fa Zhong, Jie Wang, Bao-Jie Shi, Zhen-Yu Liu, Ping-Sui Li, Xing Xiong, Shi-Quan Xu, Cheng Qiu, Yi Xiao, Si-Bo Li, Wen-Hui Tong, Jing-Ping Ge, Hang-Xu Li, Xiao-Yan Liu, Zi-Zhi Li, Xiang-Rui Kong, Jun-Lin Chen, Xue-Jiao Wen, Pan Sun, Peng-Peng Chen, Yang-Yang Li, Yang Chen, Lan-Tian Mao, Zhi-Hai Peng, Hao Li, Tong Zhang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2026-03-01
Colección:	Cardiovascular Diabetology
Materias:	Metabolic dysfunction-associated steatotic liver disease Composite triglyceride–inflammation index Cardiovascular mortality All-cause mortality Diabetes Cardiometabolic risk
Acceso en línea:	https://doi.org/10.1186/s12933-026-03119-x
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!